KP
Kavitha Prakash
About Kavitha Prakash
Data last updated:
Kavitha Prakash is a Director at Mediscribe (India) Private Limited (since 2009) and Director at Atria Clinical Research India Private Limited (since 2017). The companies operate in Business Outsourcing and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹5.91 Cr; the largest is Mediscribe (India) Private Limited at ₹5.90 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
_PRIVATE_LIMITED.webp){kind=small} Mediscribe (India) Private Limited U72300KA1999PTC024942 | Director | 01 Apr 2009 | 1999 | ₹5.90 Cr (FY 2025) | Active |
 Atria Clinical Research India Private Limited U73100KA2017PTC106019 | Director | 31 Aug 2017 | 2017 | ₹84,100 (FY 2024) | Active |
Board colleagues of Kavitha Prakash
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pradeep Shanthilal | 00735726 | Mediscribe (India) Private Limited , Atria Clinical Research India Private Limited | Director |
| Prakash Shantilal | 00572626 | Mediscribe (India) Private Limited , Atria Clinical Research India Private Limited | Director |
| Rajani Bharat Tukol | 03123750 | Mediscribe (India) Private Limited | Director |
| Sudhirkumar Ambalal Patel | 08973646 | Atria Clinical Research India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kavitha Prakash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kavitha Prakash
Kavitha Prakash currently holds 2 directorships: Mediscribe (India) Private Limited (Director, since 01 Apr 2009, revenue ₹5.90 Cr (FY 2025)); Atria Clinical Research India Private Limited (Director, since 31 Aug 2017, revenue ₹84,100 (FY 2024)).
Kavitha Prakash was first appointed on 01 Apr 2009 as Director at Mediscribe (India) Private Limited. The most recent appointment on record is 31 Aug 2017 at Atria Clinical Research India Private Limited.
The 2 current companies of Kavitha Prakash that report revenue have a combined latest revenue of ₹5.91 Cr: Mediscribe (India) Private Limited ₹5.90 Cr (FY 2025); Atria Clinical Research India Private Limited ₹84,100 (FY 2024).
The current boards of Kavitha Prakash's companies include Pradeep Shanthilal (Mediscribe (India) Private Limited), Prakash Shantilal (Mediscribe (India) Private Limited), Rajani Bharat Tukol (Mediscribe (India) Private Limited), Sudhirkumar Ambalal Patel (Atria Clinical Research India Private Limited).